GWM
OREX

Gupta Wealth Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Gupta Wealth Management’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$0 Hold
84
– – ﹤0.01% 1372
2015
Q4 		$1K Hold
84
– – ﹤0.01% 1235
2015
Q3 		$2K Hold
84
– – ﹤0.01% 1173
2015
Q2 		$4K Hold
84
– – ﹤0.01% 1063
2015
Q1 		$7K Buy
+84
New +$5.21K ﹤0.01% 842

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Gupta Wealth Management's OREX Position: Q1 2016 in Review

Gupta Wealth Management held its Orexigen Therapeutics, Inc. (OREX) position steady in Q1 2016 at 84 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

Gupta Wealth Management first reported a position in OREX in Q1 2015 and has held it in 5 quarters since. The position peaked at $7K in Q1 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.

  • Gupta Wealth Management held 84 shares of Orexigen Therapeutics, Inc. worth $0 as of Q1 2016.
  • Gupta Wealth Management left its Orexigen Therapeutics, Inc. share count unchanged in Q1 2016.
  • Orexigen Therapeutics, Inc. made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #1372 holding.
  • Gupta Wealth Management first reported a position in Orexigen Therapeutics, Inc. in Q1 2015 and has held it in 5 quarters since.
  • Gupta Wealth Management's Orexigen Therapeutics, Inc. position peaked at $7K in Q1 2015.
  • 104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.